The DGIST Center for Synapse Diversity and Specificity has identified MDGA2 as a novel causative gene for developmental and epileptic encephalopathy (DEE), a rare and intractable neurological disorder ...

Seizure control may take time—often a year or more—but most patients achieve it, bringing new hope for life with epilepsy. For millions of people living with ...

Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...

Antiseizure medications help the majority of people with focal epilepsy, a common form of the neurological disorder. Yet most will still have episodes for at least a year after their treatment begins, ...

For temporal similarity, intracranial EEG from both canines and humans exhibits large fluctuations during epileptic seizures, indicating the transferability of time-domain features across species. For ...

Patients with treatment-resistant epilepsy often cycle through multiple medications as they seek relief from the seizures that disrupt their lives. Yet in many cases, these drugs offer little benefit, ...

ChatGPT responses matched or outperformed epileptologists' responses related to the regions where epileptogenic zones are commonly located. Yet epileptologists provided more accurate responses for the ...

New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support ...

Two months later, the institute launched the Standardized Organoid Modeling Center, a national initiative financed with an initial commitment of $87 million over three years, intended to improve the ...